相关实验视频
Updated: Jun 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
严重的喘和活跃的SARS-CoV-2感染:对生物学的洞察
Sara Manti1,2, Michela Leotta1, Federica D'Amico1
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Via Consolare Valeria, 1, 98124 Messina, Italy.
在COVID-19期间管理严重的喘是复杂的. 本综述检查了生物疗法的安全性和抗病毒效果,用于患有活跃SARS-CoV-2感染的喘患者.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 喘管理因COVID-19而复杂化.
- 指导方针建议继续服用喘药物.
- 在SARS-CoV-2感染期间存在对生物安全的担忧.
研究的目的:
- 审查关于生物药物安全性和抗病毒作用的文献.
- 评估严重喘患者的生物疗法,这些患者患有活跃的COVID-19.
主要方法:
- 目前研究的文献综合.
- 包括儿科和成人人口.
- 专注于生物药物,如奥马利祖马布,杜比卢马布等.
主要成果:
- 生物疗法改善了喘控制,减少了喘恶化.
- 在活跃的SARS-CoV-2感染期间,关于免疫调节效应的问题仍然存在.
- 对于COVID-19的生物使用,需要个性化的方法.
结论:
- 对于COVID-19的严重喘患者,需要仔细考虑生物疗法.
- 需要对生物药物和SARS-CoV-2的交集进行进一步的研究.
- 个性化治疗策略对于最佳的患者结果至关重要.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
09:06Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
相关概念视频
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma III: Clinical Manifestations